{
  "docId": "019dd923-622c-750b-8b9b-a077f08347fa",
  "docSlug": "4934d687cb38",
  "documentTitle": "Valeant Pharmaceuticals International (VRX)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2015-10-30 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 13,
  "pageCount": 39,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide highlights the contradiction between Valeant's accounting consolidation of Philidor and their public claim of non-control.",
  "elementsJson": [
    "headline_text",
    "callout_box",
    "bullet_list"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-a077f08347fa/13",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.92,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "callout",
      "text": "Regulatory Risk:",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "715262c7-c364-4a3c-b0d6-656c25f2ae8e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Effective October 29th, 2015, CVS Caremark, Express Scripts and UnitedHealth/Optum announced the termination of their relationship with Philidor, comprising the vast majority of the PBM market",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-70f7-7334-b227-f2aeb7ffbcba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.92,
        "x": 0.04,
        "y": 0.26
      },
      "kind": "list",
      "text": "Valeant and Philidor operate in a highly regulated industry\nIt is legal for a manufacturer to own a pharmacy and several have/do\nWhile Valeant consolidates Philidor for accounting purposes, Valeant has stated that they do not control Philidor\nPhilidor has been accused by a former contractor and debtor of illegal activity\nRecent media reports indicate that Philidor may have engaged in fraudulent activity\nGovernment inquiries into potential legal and regulatory violations in the pharmaceutical industry are pervasive and highly fact specific",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5f6b2c47-b4f4-4232-8f38-f40af7652cc1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.88,
        "x": 0.08,
        "y": 0.65
      },
      "kind": "list",
      "text": "Effective October 29th, 2015, CVS Caremark, Express Scripts and UnitedHealth/Optum announced the termination of their relationship with Philidor, comprising the vast majority of the PBM market",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc8641bb-9c17-460a-95b8-b35afc0577eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Valeant's Use of Specialty Pharmacies (cont'd)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da8bab0e-9634-4355-b02e-9909280651f4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "9d827d66-51e1-4606-bd3e-a1218dfb07be",
      "evidence": "Highlights the contradiction between accounting consolidation and the claim of non-control.",
      "confidence": 0.85
    },
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "3f91972b-b495-48e9-84b1-f52ebbfd5bfb",
      "evidence": "The slide explicitly details accusations of illegal activity and fraudulent behavior by Philidor.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 16,
      "from": 10,
      "beatId": "8c9c2453-1cf4-4b69-b170-2662e00c1f90",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "Presentation of facts and data to support Valeant's position",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}